April 17, 2013 8:34 AM | 1 min read
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Intermolecular, Inc. (Nasdaq: IMI) today announced that it has entered into a multi-yeartechnology development and IP licensing agreement with Micron Technology,Inc. (Nasdaq: MU), focused on technology development and related IP foradvanced memory technologies. The collaboration will involve development activities at Intermolecular'sR&D center in San Jose and will leverage Intermolecular's High ProductivityCombinatorial innovation platform. The collaboration is alsoanticipated to provide time-to-market improvements for Micron throughacceleration of advanced materials development. "New materials and device architectures are increasingly needed to meetfuture embedded and mobile technology requirements, and partnering withMicron in this exciting area is a significant milestone for Intermolecular,"said Dave Lazovsky, president and CEO of Intermolecular. "Micron's global R&D efforts are focused on creating advanced memorysolutions, and we believe development of new materials technology is a keyenabler to many of our future challenges," said Scott DeBoer, Micron's vicepresident of research & development. "We look forward to working withIntermolecular to enhance our novel materials development efforts." Intermolecular's mission is to improve R&D efficiency in the semiconductorand clean energy industries through collaborations that use its HPCplatform, which allows R&D experimentation to be performed at speeds up to100 times faster than traditional methods.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.